Ticker Details
Ginkgo Bioworks Holdings, Inc.
IPO Date:	September 17, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$498.32M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.28 | 4.89%
Avg Daily Range (30 D):	$0.34 | 4.26%
Avg Daily Range (90 D):	$0.32 | 3.81%

Institutional Daily Volume
Avg Daily Volume:	14.39M
Avg Daily Volume (30 D):	.93M
Avg Daily Volume (90 D):	1.06M

Trade Size
Avg Trade Size (Sh.):	478
Avg Trade Size (Sh.) (30 D):	69
Avg Trade Size (Sh.) (90 D):	75

Institutional Trades
Total Institutional Trades:	2,386
Avg Institutional Trade:	$1.74M
Avg Institutional Trade (30 D):	$.79M
Avg Institutional Trade (90 D):	$1M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.46M
Avg Closing Trade (30 D):	$.8M
Avg Closing Trade (90 D):	$1.04M
Avg Closing Volume:	65.67K

News

Jun 28, 2026 @ 3:30 PM Palantir's Bold Biosecurity Opportunity Could Be B... Source: Rick Orford

May 12, 2026 @ 2:30 PM The $59B Quiet Shift Reshaping How Patients Access... Source: Equity Insider

Apr 8, 2026 @ 8:00 PM ProQR Highlights Pipeline Expansion and Multiple U... Source: Proqr Therapeutics N.V.

Sep 23, 2025 @ 4:00 PM A-Alpha Bio Appoints Troy Lionberger as New Chief ... Source: Troy Lionberger

Mar 3, 2025 @ 6:00 PM Global Microbial Fermentation Technology Market to... Source: Delveinsight

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-5.01	$-.75	$-1.39
Diluted EPS
Revenue	$111.86M	$20.16M	$19.47M
Gross Profit		$18.44M	$16.38M
Net Income / Loss	$-290.8M	$-46.71M	$-82.59M
Operating Income / Loss	$-290.69M	$-58.55M	$-71.37M
Cost of Revenue		$1.72M	$3.1M
Net Cash Flow	$-79.34M	$-16.65M	$-23.7M
PE Ratio

Splits
Aug 20, 2024	1:40